Tertiapin, a short peptide from honey bee venom, has been reported to specifically block the inwardly rectifying K ϩ (Kir) channels, including G protein-coupled inwardly rectifying potassium channel (GIRK) 1ϩGIRK4 heteromultimers and ROMK1 homomultimers. In the present study, the effects of a stable and functionally similar derivative of tertiapin, tertiapin-Q, were examined on recombinant human voltage-dependent Ca 2ϩ -activated large conductance K ϩ channel (BK or MaxiK; ␣-subunit or hSlo1 homomultimers) and mouse inwardly rectifying GIRK1ϩGIRK2 (i.e., Kir3.1 and Kir3.2) heteromultimeric K ϩ channels expressed in Xenopus oocytes and in cultured newborn mouse dorsal root ganglion (DRG) neurons. In twoelectrode voltage-clamped oocytes, tertiapin-Q (1-100 nM) inhibited BK-type K ϩ channels in a use-and concentrationdependent manner. We also confirmed the inhibition of recombinant GIRK1ϩGIRK2 heteromultimers by tertiapin-Q, which had no effect on endogenous depolarization-and hyperpolarization-activated currents sensitive to extracellular divalent cations (Ca 2ϩ , Mg 2ϩ , Zn 2ϩ , and Ba 2ϩ ) in defolliculated oocytes. In voltage-clamped DRG neurons, tertiapin-Q voltageand use-dependently inhibited outwardly rectifying K ϩ currents, but Cs ϩ -blocked hyperpolarization-activated inward currents including I H were insensitive to tertiapin-Q, baclofen, barium, and zinc, suggesting absence of functional GIRK channels in the newborn. Under current-clamp conditions, tertiapin-Q blocked the action potential after hyperpolarization (AHP) and increased action potential duration in DRG neurons. Taken together, these results demonstrate that the blocking actions of tertiapin-Q are not specific to Kir channels and that the blockade of recombinant BK channels and native neuronal AHP currents is use-dependent. Inhibition of specific types of Kir and voltage-dependent Ca 2ϩ -activated K ϩ channels by tertiapin-Q at nanomolar range via different mechanisms may have implications in pain physiology and therapy.